Forward Flow in Patients With Heart Failure and Functional Mitral Regurgitation: The COAPT Trial
In the COAPT trial, lower baseline forward flow was associated with worse outcomes in medically managed patients, and those with low baseline forward flow derived the greatest absolute benefit from TEER. However, measured forward flow did not improve with TEER during the 2-year follow-up.
Authors
- D. Scott Lim (ORCID: https://orcid.org/0000-0001-6951-6660)
- Yanru Li (ORCID: https://orcid.org/0000-0001-8440-9337)
- Zachary M. Gertz (ORCID: https://orcid.org/0000-0002-9613-5246)
- Michael J. Mack (ORCID: https://orcid.org/0000-0002-3148-9158)
- Michael Schonning
- Björn Redfors (ORCID: https://orcid.org/0000-0002-4155-4451)
- Saibal Kar (ORCID: https://orcid.org/0000-0003-1547-4869)
- Gregg W. Stone (ORCID: https://orcid.org/0000-0002-3416-8210)
- Neil J. Weissman
- Federico M. Asch (ORCID: https://orcid.org/0000-0002-1744-5271)
- Zhipeng Zhou (ORCID: https://orcid.org/0000-0003-0775-8220)
- W. Todd Abraham (ORCID: https://orcid.org/0000-0002-2607-7431)
- JoAnn Lindenfeld (ORCID: https://orcid.org/0000-0001-9207-3634)
- Philippe Pibarot
Institutions
- Virginia Commonwealth University (US)
- Cornell University (US)
- Bakersfield Heart Hospital (US)
- Sahlgrenska University Hospital (SE)
- St. Francis Hospital (US)
- Lung Institute (US)
- Baylor Medical Center at Garland (US)
- Heart Hospital Baylor Plano (US)
- Los Robles Hospital & Medical Center (US)
- Cardiovascular Research Foundation (US)
- Vanderbilt Health (US)
- Université Laval (CA)
- Weill Cornell Medicine (US)
- University of Virginia (US)
- The Ohio State University (US)
- MedStar Health (US)
- University of Gothenburg (SE)
- Icahn School of Medicine at Mount Sinai (US)
- Core Laboratories (United States) (US)
Publication Details
- Journal
- Journal of the Society for Cardiovascular Angiography & Interventions
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1016/j.jscai.2025.102609
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00